NCT00921492

Brief Summary

Hypothesis The overall hypothesis is that non-obese (BMI \<30) women with PCOS have high luteinising hormone (LH) and cortisol pulse frequency and amplitude and that repeated low-frequency EA restore these alterations and induce ovulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 12, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 16, 2009

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

August 15, 2018

Status Verified

August 1, 2018

Enrollment Period

1.8 years

First QC Date

June 12, 2009

Last Update Submit

August 13, 2018

Conditions

Keywords

Luteinizing hormoneCortisolHPA axisHPO axisOvulationHeart rate variabilityPsychological distress and quality of life

Outcome Measures

Primary Outcomes (1)

  • Frequent blood sampling every 10th minute during an overnight stay in order to measure changes in LH and cortisol pulsatility before and after treatment. A third assessment will be made in those participants who ovulate during the 14 week study.

    16 weeks

Secondary Outcomes (1)

  • Ovulation, health related quality of life

    16 weeks

Study Arms (2)

Low-frequency electro-acupuncture

EXPERIMENTAL
Device: Low-frequency electro-acupuncture (EA)

Meeting a therapist - attention

ACTIVE COMPARATOR
Other: Meeting a therapist - attention control

Interventions

2 Hz EA during 30 minutes, twice a week, 14 weeks.

Low-frequency electro-acupuncture

Meeting a therapist, twice a week during 30 minutes in order to control for the increased amount of attention.

Meeting a therapist - attention

Eligibility Criteria

Age18 Years - 39 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years, inclusive
  • ≤ BMI
  • History of irregular menstrual cycles
  • Clinical and/or biochemical androgen excess (determined during screening)

You may not qualify if:

  • History or clinical manifestation of; cardiovascular disease, diabetes (Type 1 or Type 2), any other significant endocrine or metabolic disorder.
  • Regular use of medications for weight control, psychosis and thyroid disease. A 3 month washout period will be permitted for contraceptives.
  • Pregnant or breast-feeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Neuroscience and Physiology, Sahlgrenska Academy, Göteborg University

Gothenburg, 40530, Sweden

Location

Related Publications (1)

  • Johansson J, Redman L, Veldhuis PP, Sazonova A, Labrie F, Holm G, Johannsson G, Stener-Victorin E. Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab. 2013 May 1;304(9):E934-43. doi: 10.1152/ajpendo.00039.2013. Epub 2013 Mar 12.

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2009

First Posted

June 16, 2009

Study Start

February 1, 2009

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

August 15, 2018

Record last verified: 2018-08

Locations